T1	Participants 514 533	12 autistic subject
T2	Participants 533 664	s completed a 10-week, double-blind, crossover comparison of clomipramine and placebo, and 12 different subjects completed a simila
T3	Participants 767 803	30 male and female autistic patients
T4	Participants 823 844	24 completed the stud
